Gottesdiener Andrew has filed 3 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 14461 shares of Apogee Therapeutics, Inc. ($APGE) on June 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | Apogee Therapeutics, Inc. | $APGE | Gottesdiener Andrew | Director | A | Stock Option (Right to Buy) | 14461 | $0.00 | 14,461.0000 | 46,016,542 | 9999.99% | 0.03% |
| June 5, 2024 | Apogee Therapeutics, Inc. | $APGE | Gottesdiener Andrew | Director | A | Stock Option (Right to Buy) | 10370 | $0.00 | 10,370.0000 | 0 | 9999.99% | 0.00% |
| July 13, 2023 | Apogee Therapeutics, Inc. | $APGE | Gottesdiener Andrew | Director | A | Stock Option (Right to Buy) | 47758 | $0.00 | 47,758.0000 | 0 | 9999.99% | 0.00% |